Benzimidazoles
Cayman Chemical Albendazole sulfon-d3 5mg
An internal standard for the quantification of albendazole sulfone by GC- or LC-MS
Medchemexpress LLC 4-methoxy-2-nitroacetanilide | 119-81-3 | MFCD00017018 | 25g
Omeprazole impurity 1 is an impurity ofOmeprazole (HY-B0113)
Medchemexpress LLC (R)-Omeprazole (sodium) | 161796-77-6 | 98.1% | 25 MG
(R)-Omeprazole sodium is a gastric acid resistant compound that inhibits gastric acid secretion. It is metabolized in vivo, primarily by cytochrome P450 enzymes, and its interaction with mannitol may affect its bioavailability in formulations. It exhibits reversible direct and metabolism-dependent inhibition of CYP2C19.
- Gastric acid resistant compound
- Inhibits gastric acid secretion
- Metabolized by cytochrome P450 enzymes
- Reversible direct and metabolism-dependent inhibition of CYP2C19
- For research use only
Medchemexpress LLC Albendazole sulfoxide | 54029-12-8 | 99.2% | 1 ML
Albendazole sulfoxide, also known as Ricobendazole, is the primary active metabolite of Albendazole. It exhibits anti-parasitic effects against *Echinococcus multilocularis* Metacestodes, demonstrating parasitocidal activity in vitro and reducing cyst size in vivo.
- Main active metabolite of Albendazole
- Exhibits anti-parasitic effects
- Active against *Echinococcus multilocularis* Metacestodes
- Demonstrates parasitocidal effects in vitro
- Reduces cyst size and weight in vivo
Medchemexpress LLC Omeprazole | 73590-58-6 | 99.96% | C17H19N3O3S | 5 G
Omeprazole (H 16868) is a proton pump inhibitor (PPI) primarily used for treating acid-related gastrointestinal disorders. It functions by competitively inhibiting CYP2C19 activity and suppressing gastric acid secretion. Additionally, this compound exhibits antibacterial properties against Gram-positive and Gram-negative bacteria and acts as a brain-penetrant neutral sphingomyelinase (N-SMase) inhibitor.
- Treats dyspepsia, peptic ulcer disease, gastroesophageal reflux disease, laryngopharyngeal reflux, and Zollinger-Ellison syndrome.
- Inhibits growth of Gram-positive and Gram-negative bacteria.
- Functions as a proton pump inhibitor.
- Competitively inhibits CYP2C19 activity.
- Inhibits gastric acid secretion.
- Acts as a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor.
Medchemexpress LLC Omeprazole | 73590-58-6 | 100.0% | C17H19N3O3S | 10 G
Omeprazole is a proton pump inhibitor (PPI) primarily used for treating acid-related gastrointestinal disorders. It competitively inhibits CYP2C19 activity, inhibits the growth of both Gram-positive and Gram-negative bacteria, and acts as a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor.
- Treats dyspepsia, peptic ulcer disease, and gastroesophageal reflux disease.
- Effective for laryngopharyngeal reflux and Zollinger-Ellison syndrome.
- Inhibits gastric acid secretion.
- Competitively inhibits CYP2C19 activity.
- Inhibits growth of Gram-positive and Gram-negative bacteria.
- Functions as a brain penetrant neutral sphingomyelinase (N-SMase) inhibitor.
Sigma Aldrich Fine Chemicals Biosciences Pantoprazole sodium hydrate >=98% (HPLC) | 718635-09-7 | 10MG
Pantoprazole sodium hydrate >=98% (HPLC) | Purity: >=98% (HPLC) | 718635-09-7 | 10MG
Medchemexpress LLC Omeprazole (Standard) | 73590-58-6 | 99.9% | C17H19N3O3S | 5 MG
Omeprazole (Standard) is an analytical standard used for research and analytical applications, such as qualitative, quantitative, and methodological experiments in HPLC, GC, and MS.
- Analytical standard of omeprazole
- Proton pump inhibitor (PPI)
- Competitive inhibitor of CYP2C19 activity
- Inhibits growth of Gram-positive and Gram-negative bacteria
- Potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor
eMolecules 89352-76-1 | Ambeed | N-Methyl Omeprazole | 100mg | 600851645 | A638530 | MFCD19441777 | 359.44 | C18H21N3O3S
Ambeed | N-Methyl Omeprazole | 100mg | 600851645 | A638530 | 89352-76-1 | MFCD19441777 | 359.440 | C18H21N3O3S
Cayman Chemical Omeprazole-d3 5mg
An internal standard for the quantification of omeprazole by GC- or LC-MS